Amgen announced that its subcutaneous on‑body injector version of Tepezza, called Tepezza OBI, met both primary and key secondary endpoints in a late‑stage trial, showing 77% of patients achieved a meaningful reduction in eye bulging. The efficacy was comparable to the existing intravenous formulation, with a 3.17 mm average proptosis reduction and a safety profile consistent with the marketed drug. The results could revive growth for the $2 billion‑a‑year franchise, which has stalled due to infusion‑center logistics. Analysts see the convenient delivery method as a way to expand the thyroid eye disease market.

Private equity in health care and life sciences faces a turbulent 2026 as the new administration rolls back ACA subsidies and implements the One Big Beautiful Bill Act, slashing Medicaid spending by roughly $800 billion over the next decade. The loss...
VDyne received FDA approval for an investigational device exemption to launch its pivotal TRIVITA trial of a transcatheter tricuspid valve replacement system. The study will assess safety and efficacy in patients with severe symptomatic tricuspid regurgitation, a condition affecting roughly...

The FDA issued an urgent alert that B. Braun’s recent tubing‑resin change in its Streamline Airless System and B3 Low Volume hemodialysis bloodlines is causing small air bubbles to adhere inside the arterial line. These bubbles trigger machine alarms, halt treatment...

On August 25, 2026 the FDA will host a hybrid Patient‑Focused Drug Development meeting dedicated to non‑healing chronic wounds. The public session runs from 10 a.m. to 4:30 p.m. ET and combines a virtual webcast with an in‑person gathering at the White Oak Campus....
The White House’s FY budget proposes a sizable increase for the FDA, positioning Dr. Robert Makary to spearhead regulatory reforms aimed at accelerating U.S. biotech development. The plan includes policy changes that would shorten clinical‑trial timelines, lower fees for early‑stage...

Rural healthcare organizations are bracing for reduced Medicaid funding while eyeing the $10 billion‑per‑year Rural Health Transformation Program. Tight cash reserves are driving IT leaders to prioritize short‑term resilience, cost‑cutting measures and rapid‑ROI technologies such as AI‑enabled documentation, cloud migration, and...

Interest in medicinal cannabis for children with autism, ADHD and Tourette's has grown, prompting the Australian Therapeutic Goods Administration to confirm that doctors are prescribing it for these conditions. While parents hope it could reduce reliance on stimulants, antidepressants and...
A new analysis presented at CROI 2026 used International Epidemiology Databases to Evaluate AIDS (IeDEA) data from Africa, Asia‑Pacific, and Latin America, covering over 90% of the world’s children with HIV. The study found that dolutegravir initiates modest early weight gain...
Health policy experts are warning that the Centers for Medicare & Medicaid Services is exploring automatic enrollment of Medicare beneficiaries into Medicare Advantage (MA) plans. They argue the move could curtail seniors' ability to choose alternative coverage and drive up...
Mayo Clinic researchers introduced a new method called the Ratio of Immunogenicity (ROI) to identify proteins that provoke strong immune responses. By measuring protein abundance and immune activation, the ROI ranks proteins from most to least immunogenic, revealing that mitochondrial...

Legion Health, a San Francisco startup, received Utah regulatory approval to let its AI chatbot renew psychiatric prescriptions for a limited set of antidepressants such as Prozac and Zoloft. The system can only prescribe drugs previously authorized by a human...

The Holland Foundation for Sight Restoration is scaling its Cincinnati Protocol for ocular surface stem‑cell transplantation by establishing “centers of excellence” and expanding surgeon education. To date, five centers—from Cincinnati to UC Irvine, Virginia Eye Consultants, and Massachusetts Eye and...
In a recent HFMA podcast, senior editor Erika Grotto and FinThrive’s Jonathan Wiik dissect a high‑profile antitrust lawsuit targeting alleged price‑fixing among hospital providers. The discussion also explores how artificial intelligence can be woven into the patient‑experience journey to boost...
Cedars‑Sinai researchers have created a geospatial algorithm that identifies clusters of sudden cardiac arrests and recommends optimal public AED locations within 200 meters of those hotspots. The model analyzed incidents from 2012‑2023 in Ventura County, California, and Multnomah County, Oregon,...
Health Level Seven International (HL7) has launched the Caliper FHIR Accelerator implementation community to accelerate real‑world exchange of data from medical and personal health devices. The multi‑stakeholder group builds on the Gemini Device Interoperability Program and will use FHIR standards,...
About 80% of breast biopsies in the United States turn out benign, prompting calls for less invasive diagnostics. Researchers have developed a hand‑held device that merges traditional ultrasound with diffuse optical tomography (DOT), which maps blood hemoglobin and oxygen levels...
A University at Buffalo mixed‑methods study observed 20 life‑enhancement sessions in a Canadian long‑term care facility, identifying how activity design and delivery affect resident engagement. Researchers tracked self‑initiative, social interaction, emotional expression, and distractions, finding that interactive, music‑rich, facilitator‑led activities...

The FDA’s Center for Drug Evaluation and Research has launched the Drug Info Rounds video series, a free on‑demand library that educates health‑care professionals on drug safety, regulatory processes, and compliance. The series covers topics such as MedWatch reporting, Medication...

A recent study published in Cell Reports Medicine shows that large language models can generate biomedical analysis code that matches or exceeds expert performance. Junior researchers, including a graduate student and a high‑school student, used simple prompts to produce accurate...

Smart storage systems are becoming essential in healthcare facilities, safeguarding medications, patient records, and equipment through locked cabinets and digital tracking. Organized layouts and frequency‑based shelving cut staff search time, allowing more focus on patient care. Real‑time inventory platforms alert...

Valley Family Health Care (VFHC) disclosed a TriZetto Provider Solutions breach on Jan. 12 that exposed the personal and health‑insurance data of 4,300 patients. In March, the cyber‑crime group Insomnia listed VFHC on a dark‑web leak, claiming more than one million...

A new study published in the Journal of the American Heart Association finds that children born after a placental abruption face a dramatically higher risk of cardiovascular disease and death by age 28. The analysis of 2,949,992 singleton pregnancies from...

Researchers identified the chromatin remodeler RUVBL2 as a key driver of metabolic reprogramming in microglia that underlies post‑operative delirium in aged rats. Suppressing RUVBL2 reversed the glycolytic shift, boosted ATP production, reduced stress‑granule accumulation, and restored performance on Barnes maze...

Healthcare providers rely on sterile barrier systems to keep medical devices and products free from microbial contamination. By integrating robust packaging, sealing methods, and controlled storage, these barriers protect patient safety throughout the product lifecycle. Mapping each handling, transport, and...
Cardiovascular Consultants, a Phoenix cardiology practice owned by Fresenius Medical Care, agreed to pay $3.85 million to settle a class‑action lawsuit stemming from a September 2023 data breach. The breach potentially exposed personal data of 500,000 patients and 200 employees, including Social...

Healthcare facilities often suffer from confusing layouts, poor signage, and inadequate wayfinding tools, leading to heightened patient stress and missed appointments. The article highlights how clear signage, color‑coded cues, and consistent design can streamline navigation. It also emphasizes the role...
Corewell Health, a Michigan nonprofit system, partnered with Cadence to embed remote patient monitoring (RPM) into primary‑care workflows for hypertension, diabetes and heart‑failure patients. The program achieved over 80% patient engagement and delivered measurable clinical gains in four months, including...
The Biotechnology Innovation Organization (BIO) submitted comments to the USTR’s 2026 Special 301 Report urging stronger global enforcement of intellectual‑property (IP) rights for biotech. BIO argues that weak IP protections in markets such as Colombia, Russia and Brazil create barriers...
A recent randomized VIVID trial examined vitamin D₃ supplementation in newly diagnosed COVID‑19 patients and found a non‑significant trend toward fewer long‑COVID symptoms at eight weeks. While primary outcomes such as healthcare utilization were unchanged, researchers noted that delayed treatment...
Jiangsu and Shanghai Hengrui have patented selective Nav1.8 sodium‑channel blockers that show pre‑clinical analgesic efficacy with fewer side effects. New hematopoietic stem‑cell research links chronic inflammation to early leukemic transformation, identifying inflammatory pathways as therapeutic targets. Infinimmune presented pre‑clinical data...

Biopharma financing nearly doubled year‑over‑year, reaching about $25.1 billion, fueling a wave of early‑stage research. Jiangsu and Shanghai Hengrui patented novel Nav1.8 sodium‑channel blockers aimed at chronic pain relief. New hematopoietic stem‑cell studies link inflammation to the earliest stages of leukemia,...
BioWorld’s April 6, 2026 regulatory snapshot aggregates the day’s key FDA and global health authority actions across biopharma, medical technology, and diagnostics. The page links to data snapshots, special reports, infographics and trend analyses covering topics such as mRNA vaccine research, GLP‑1...

St. Luke's Medical Center announced it will proceed with a massive expansion despite rising costs from the Middle East crisis. The group plans to break ground on a new 500‑bed Aseana hospital in Parañaque costing about P18 billion (≈$324 million) with an...
Researchers at UCSF surveyed 168 patients about a prototype over‑the‑counter medication abortion kit, finding 88% concordance between self‑assessment and clinician eligibility. The study, published in JAMA Internal Medicine, suggests patients can reliably determine suitability for mifepristone‑misoprostol regimens without a prescriber....
Amgen announced that its injectable formulation of Tepezza achieved its primary endpoint in a Phase 3 trial for thyroid eye disease (TED). The data suggest the drug can be administered subcutaneously, offering a more convenient alternative to the current intravenous...

New research published in JAMA Pediatrics shows that more than one‑fifth of adolescents in a Pennsylvania health system were either unvaccinated or incompletely vaccinated against HPV before becoming sexually active. While 79% completed the series before debut, 12% received no...
OneCyte and Kemp Proteins have formed a strategic partnership that fuses OneCyte’s high‑throughput single‑cell cloning platform with Kemp’s machine‑learning‑driven protein design system, PROTiQ. The combined workflow uses in‑silico sequence evaluation to flag developability risks, then rapidly screens thousands of clones...
Hologic announced that CEO Steve MacMillan will retire as the company completes a Blackstone‑TPG go‑private transaction valued at $18.3 billion. The deal, which received all regulatory approvals, will close Tuesday and delist Hologic from Nasdaq, paying shareholders $76 per share plus...
San Francisco AI firm Anthropic announced a $400 million acquisition of stealth biotech Coefficient Bio, signaling its push into drug discovery. The purchase aims to integrate Anthropic’s large‑language‑model capabilities with biotech research pipelines. In parallel, Praxis Therapeutics disclosed encouraging Phase 1/2 data...
Takeda announced the termination of its eight‑year partnership with Denali Therapeutics, returning full rights to the experimental drug DNL593 ahead of its upcoming Phase I trial. The move is part of Takeda's broader restructuring aimed at streamlining its portfolio and...

The American Dental Association reports roughly 40.2 million U.S. adults are edentulous, underscoring a sizable market for tooth replacement. Modern complete dentures have evolved with digital scanning, computer‑aided design, and customized aesthetics, delivering better fit, comfort, and facial support. Immediate dentures...

The 2025‑2030 Dietary Guidelines for Americans (DGA) rejected 30 of the 56 recommendations from the Dietary Guidelines Advisory Committee (DGAC) after labeling the committee’s health‑equity focus as biased. Instead, the administration relied on a newly commissioned “Scientific Foundation” report that...

A new study reveals that African populations are dramatically underrepresented in cardiovascular clinical trials, with less than 4 % of 2,472 randomized controlled trials (RCTs) conducted exclusively in Africa and only 0.6 % appearing in top cardiology journals. Lead author Bamba Gaye...

Skull fractures can become fatal if five key warning signs are missed: loss of consciousness, unequal pupils, worsening headache, fluid leaking from the nose or ears, and seizures. These symptoms indicate brain injury, bleeding, or increased intracranial pressure and require...

In February, Kezar Life Sciences secured an FDA agreement for a clinical trial on autoimmune hepatitis, but the meeting was cancelled four months late, prompting the biotech to begin winding down. Meanwhile, U.S. physicians are increasingly prescribing oral GLP‑1 weight‑loss...

The MOMENTUM study of 1,086 patients with resistant hypertension found that 27.3% had endogenous hypercortisolism. Nearly a quarter of those positive cases displayed adrenal nodules, and 21.5% also had primary hyperaldosteronism, with 5.9% harboring both disorders. Hypercortisolism was associated with...

American Association of Clinical Endocrinology (AACE) released its 2026 consensus algorithm for managing adult type 2 diabetes, the first revision since 2023. The update introduces a diagnostic classification chart to confirm type 2 diabetes and adds metabolic dysfunction‑associated steatotic liver disease (MASLD)...

Researchers have engineered a bifunctional antibody fragment that simultaneously blocks Marburg virus attachment and neutralizes the exposed receptor‑binding site after the virus undergoes its conformational change. By mimicking the host cell receptor, the antibody tightly binds the viral protein, shutting...
Microsoft’s new low‑code AI platform lets healthcare staff build custom agents without programming expertise, enabling rapid solutions for clinical and back‑office challenges. By offering drag‑and‑drop interfaces and pre‑built connectors to electronic health records and billing systems, the tool democratizes agentic...